Tag Archives: TG Therapeutics

Analysts Offer Insights on Healthcare Companies: TG Therapeutics (NASDAQ: TGTX) and Allogene Therapeutics (NASDAQ: ALLO)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on TG Therapeutics (TGTX – Research Report) and Allogene Therapeutics (ALLO – Research Report) with bullish sentiments. TG Therapeutics (TGTX) H.C. Wainwright analyst

B.Riley FBR Believes TG Therapeutics (NASDAQ: TGTX) Won’t Stop Here

B.Riley FBR analyst Mayank Mamtani reiterated a Buy rating on TG Therapeutics (TGTX – Research Report) yesterday and set a price target of $37.00. The company’s shares closed last Friday at $19.30, close to its 52-week high of $21.59. According

H.C. Wainwright Believes TG Therapeutics (NASDAQ: TGTX) Still Has Room to Grow

In a report released today, Edward White from H.C. Wainwright reiterated a Buy rating on TG Therapeutics (TGTX – Research Report), with a price target of $32.00. The company’s shares closed last Tuesday at $20.30, close to its 52-week high

H.C. Wainwright Believes TG Therapeutics (NASDAQ: TGTX) Won’t Stop Here

H.C. Wainwright analyst Edward White reiterated a Buy rating on TG Therapeutics (TGTX – Research Report) today and set a price target of $32.00. The company’s shares closed last Tuesday at $15.95, close to its 52-week high of $16.22. According

B.Riley FBR Keeps a Buy Rating on TG Therapeutics (TGTX)

In a report issued on March 13, Mayank Mamtani from B.Riley FBR maintained a Buy rating on TG Therapeutics (TGTX – Research Report), with a price target of $25.00. The company’s shares closed last Monday at $8.91. According to TipRanks.com,

H.C. Wainwright Keeps Their Buy Rating on TG Therapeutics (TGTX)

H.C. Wainwright analyst Edward White reiterated a Buy rating on TG Therapeutics (TGTX – Research Report) today and set a price target of $20.00. The company’s shares closed last Monday at $7.68. According to TipRanks.com, White is a 5-star analyst